Bibliography
- Lee M . Basic Skills in Interpreting Laboratory Data. 4th Edition. Bethesda, MD, USA American Society of Health-System Pharmacists.832 (2009).
- Benet LZ , HoenerBA. Changes in plasma protein binding have little clinical relevance. Clin. Pharmacol. Ther. 71, 115–121 (2002).
- Berezhkovskiy LM . On the influence of protein binding on pharmacological activity of drugs. J. Pharm. Sci. 99, 2153–2165 (2010).
- Musteata FM , PawliszynJ, QianMG, WuJT, MiwaGT. Determination of drug plasma protein binding by solid-phase microextraction. J. Pharm. Sci. 95, 1712–1722 (2006).
- Berezhkovskiy LM . On the possibility of self-induction of drug protein binding. J. Pharm. Sci. 99, 4400–4405 (2010).
- Dawidowicz AL , KobielskiM, PieniadzJ. Anomalous relationship between free drug fraction and its total concentration in drug–protein systems – II. Binding of different ligands to plasma proteins. Eur. J. Pharm. Sci. 35, 136–141 (2008).
- Dawidowicz AL , KobielskiM, PieniadzJ. Anomalous relationship between free drug fraction and its total concentration in drug–protein systems – I. Investigation of propofol binding in model HSA solution. Eur. J. Pharm. Sci. 34, 30–36 (2008).
- Vuignier K , SchapplerJ, VeutheyJL, CarruptPA, MartelS. Drug–protein binding. a critical review of analytical tools. Anal. Bioanal. Chem. 398, 53–66 (2010).
- Xuan H , JosephKS, WaCL, HageDS. Biointeraction analysis of carbamazepine binding to α(1)-acid glycoprotein by high-performance affinity chromatography. J. Sep. Sci. 33, 2294–2301 (2010).
- Zsila F , VisyJ, MadyG, FitosI. Selective plasma protein binding of antimalarial drugs to α(1)-acid glycoprotein. Bioorg. Med. Chem. 16, 3759–3772 (2008).
- Theodoridis G . Application of solid-phase microextraction in the investigation of protein binding of pharmaceuticals. J. Chromatogr. B830, 238–244 (2006).
- Vuckovic D , CudjoeE, MusteataFM, PawliszynJ. Automated solid-phase microextraction and thin-film microextraction for high-throughput analysis of biological fluids and ligand–receptor binding studies. Nat. Protoc. 5, 140–161 (2010).
- Musteata ML , MusteataFM. Analytical methods used in conjunction with SPME. A review of recent bioanalytical applications. Bioanalysis1, 1081–1102 (2009).
- Chen JZ , OhnmachtC, HageDS. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography. J. Chromatogr. B809, 137–145 (2004).
- Soman S , YooMJ, JangYJ, HageDS. Analysis of lidocaine interactions with serum proteins using high-performance affinity chromatography. J. Chromatogr. B878, 705–708 (2010).
- Liu RY , MengQC, XiJet al. Comparative binding character of two general anaesthetics for sites on human serum albumin. Biochem. J. 380, 147–152 (2004).
- Zhou R , LiuR. Does bilirubin change the free concentration of propofol? Acta Anaesthesiol. Scand. 54, 653–654 (2010).
- Vaes WHJ , Urrestarazu Ramos E, Verhaar HJM, Seinen W, Hermens JLM. Measurement of the free concentration using solid-phase microextraction. binding to protein. Anal. Chem. 68, 4463–4467 (1996).
- Heringa MB , HogevonderC, BusserF, HermensJLM. Measurement of the free concentration of octylphenol in biological samples with negligible depletion-solid-phase microextraction (nd-SPME). Analysis of matrix effects. J. Chromatogr. B834, 35–41 (2006).
- Kodama H , KodamaY, ItokazuN, ShinozawaS, KanemaruR, SugimotoT. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy. J. Clin. Pharm. Ther. 26, 175–179 (2001).
- Iwamoto T , KagawaY, NaitoY, KuzuharaS, OkudaM. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding. Biopharm. Drug Dispos. 27, 77–84 (2006).
- Anderson GD , PakC, DoaneKWet al. Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia. Ann. Pharmacother. 31, 279–284 (1997).
- Kodama H , KodamaY, ShinozawaS, KanemaruR, ItokazuN, SugimotoT. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy. Int. J. Clin. Pharmacol. Ther. 38, 25–29 (2000).
- Mamiya K , YukawaE, MatsumotoT, AitaC, GotoS. Synergistic effect of valproate coadministration and hypoalbuminemia on the serum-free phenytoin concentration in patients with severe motor and intellectual disabilities. Clin. Neuropharmacol. 25, 230–233 (2002).
- Alvarez MTR , ValinoLE, GabrielEF, MaciasMO, LayaBS, HerranzIM. Relation between total and unbound valproate concentration and seric albumin. Pharm. World Sci. 32, 289–289 (2010).
- Ueshima S , AibaT, SatoTet al. Individualized dosage adjustment of valproic acid based on unbound serum concentration in intractable epileptic children. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 128, 92–92 (2008).
- Dutta S , FaughtE, LimdiNA. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy. J. Clin. Pharm. Ther. 32, 365–371 (2007).
- Sproule B , Nava-OcampoAA, KapurB. Measuring unbound versus total valproate concentrations for therapeutic drug monitoring. Ther. Drug Monit. 28, 714–715 (2006).
- Berezhkovskiy LM . On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities. Determination of the possible variation of the unbound drug fraction and calculation of the number of binding sites of the protein. J. Pharm. Sci. 96, 249–257 (2007).
- Berezhkovskiy LM . Consideration of the linear concentration increase of the unbound drug fraction in plasma. J. Pharm. Sci. 98, 383–393 (2009).
- Berezhkovskiy LM . Some features of the kinetics and equilibrium of drug binding to plasma proteins. Expert Opin. Drug Metab. Toxicol. 4, 1479–1498 (2008).
- Barrail-Tran A , MentreF, CossonCet al. Influence of α-1 glycoprotein acid concentrations and variants on atazanavir pharmacokinetics in hiv-infected patients included in the ANRS 107 trial. Antimicrob. Agents Chemother. 54, 614–619 (2009).
- Shakalisava Y , ReganF, McKeonL. Feasibility of the ultrafiltration procedure when studying pharmacological effect of anthracyclines and taxanes. Presented at:Pittcon. Atlanta, GA, USA 13–18 March (2011).
- Vita M , Abdel-RehimM, NilssonCet al. Stability, pKa and plasma protein binding of roscovitine. J. Chromatogr. B821, 75–80 (2005).
- Nowak I , ShawLM. Mycophenolic-acid binding to human serum-albumin - characterization and relation to pharmacodynamics. Clin Chem41, 1011–1017 (1995).
- Chen S , ZhangJ, HuangTN, WuJT, LeeFW, QianMG. A practical method for measuring free drug concentration in whole blood using rapid equilibrium dialysis (RED) device. Drug Metab. Rev. 39, 290 (2007).
- Liu XR . Unbound brain concentration determines brain receptor occupancy. Drug Metab. Rev. 41, 27 (2009).
- Liu XR , VilenskiO, KwanJ, ApparsundaramS, WeikertR. Unbound in brain concentration determines receptor occupancy. A correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds rats. Drug Metab. Dispos. 37, 1548–1556 (2009).
- Hsueh MM , WangMM, SleckzaBet al. Theory vs realty. Is free drug concentration in adipose equal to free concentration in plasma? Drug Metab. Rev . 41, 130 (2009).
- Li J , BrahmerJ, MessersmithW, HidalgoM, BakerSD. Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells. In vitro and in cancer patients. Invest. New Drugs24, 291–297 (2006).
- Vorum H , HonoreB. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy. J. Pharm. Pharmacol. 48, 870–875 (1996).
- Vorum H , JorgensenHRI, BrodersenR. Variation in the binding-affinity of warfarin and phenprocoumon to human serum-albumin in relation to surgery. Eur. J. Clin. Pharmacol. 44, 157–162 (1993).
- Hackbarth JS , HoyneJB, GrebeSK, SinghRJ. Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration. Steroids76, 48–55 (2011).
- Speeckaert MM , TaesYE, De Buyzere ML, Christophe AB, Kaufman JM, Delanghe JR. Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann. Clin. Biochem. 47, 143–150 (2010).
- Calligaris SD , BellarosaC, GiraudiP, WennbergRP, OstrowJD, TiribelliC. Cytotoxicity is predicted by unbound and not total billrubin concentration. Pediatr. Res. 62, 576–580 (2007).
- Musteata ML , MusteataFM, PawliszynJ. Biocompatible solid phase microextraction coatings based on polyacrylonitrile and SPE phases. Anal. Chem. 79, 6903–6911 (2007).
- Kuang B , KingL, WangHF. Therapeutic monoclonal antibody concentration monitoring. Free or total? Bioanalysis2, 1125–1140 (2010).
- Lee JW , KelleyM, KingLEet al. Bioanalytical approaches to quantify ‘total’ and ‘free’ therapeutic antibodies and their targets. Technical challenges and PK/PD applications over the course of drug development. AAPS J. 13, 99–110 (2011).
- Bauer LA . Phenytoin. In:Applied Clinical Pharmacokinetics. McGraw-Hill Medical. USA 485–490 (2008).
- Mauro LS , MauroVF, BachmannKA, HigginsJT. Accuracy of two equations in determining normalized phenytoin concentrations. DICP23, 64–68 (1989).
- Tandon M , PandhiR, GargSK, PrabhakarSK. Serum albumin-adjusted phenytoin levels. an approach for predicting drug efficacy in patients with epilepsy, suitable for developing countries. Int. J. Clin. Pharmacol. Ther. 42, 550–555 (2004).